Ryan Martins 89bio, Inc. (ETNB) insider trading activity

Ryan Martins is Chief Financial Officer of 89bio, Inc.. Currently has a direct ownership of 253,496 shares of ETNB, which is worth approximately $3.72 Million. The most recent transaction as insider was on Feb 17, 2023, when has been sold 1,750 shares (Common Stock) at a price of $13.97 per share, resulting in proceeds of $24,447. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 253K

2.94% 3M change

147.02% 12M change

Total Value Held $3.72 Million

Ryan Martins Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 17 2023	SELL Payment of exercise price or tax liability	$24,447 $13.97 p/Share	1,750 Reduced 2.78%	61,118 Common Stock
Feb 09 2023	BUY Grant, award, or other acquisition	-	30,000 Added 32.3%	62,868 Common Stock
Feb 08 2023	SELL Open market or private sale	$21,326 $14.41 p/Share	1,480 Reduced 4.31%	32,868 Common Stock
Feb 05 2023	SELL Payment of exercise price or tax liability	$7,838 $13.24 p/Share	592 Reduced 1.69%	34,348 Common Stock
Feb 03 2023	SELL Open market or private sale	$46,372 $12.91 p/Share	3,592 Reduced 9.22%	35,368 Common Stock
Feb 03 2023	BUY Exercise of conversion of derivative security	$9,330 $3.11 p/Share	3,000 Added 7.15%	38,960 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$4,916 $12.05 p/Share	408 Reduced 1.12%	35,960 Common Stock
Jan 03 2023	SELL Open market or private sale	$74,396 $12.51 p/Share	5,947 Reduced 14.05%	36,368 Common Stock
Sep 28 2022	SELL Payment of exercise price or tax liability	$11,624 $5.76 p/Share	2,018 Reduced 4.55%	42,315 Common Stock
Sep 28 2022	BUY Grant, award, or other acquisition	-	5,833 Added 11.63%	44,333 Common Stock
Sep 09 2022	BUY Grant, award, or other acquisition	-	15,000 Added 28.04%	38,500 Common Stock
Feb 17 2022	BUY Grant, award, or other acquisition	-	16,000 Added 40.51%	23,500 Common Stock
Feb 05 2022	SELL Payment of exercise price or tax liability	$5,345 $5.23 p/Share	1,022 Reduced 4.35%	22,478 Common Stock
Apr 19 2021	SELL Open market or private sale	$250,000 $25.0 p/Share	10,000 Reduced 57.14%	7,500 Common Stock
Apr 19 2021	BUY Exercise of conversion of derivative security	$31,100 $3.11 p/Share	10,000 Added 36.36%	17,500 Common Stock
Feb 05 2021	BUY Grant, award, or other acquisition	-	7,500 Added 50.0%	7,500 Common Stock

Ryan Martins

Chief Financial Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ETNB shares.

Notify only if

Value

Insider Trading

Get notified when an 89bio, Inc. insider buys or sells ETNB shares.

Notify only if

Operation

Value

Type

News

Receive news related to 89bio, Inc.

Track Activities on ETNB

Account